About us: The
legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years.
Established in 1907 with an objective to develop and revolutionize the
Pharmaceutical and Drug industry in the Indian subcontinent, Alembic
Pharmaceuticals Limited today is one of the leading pharmaceutical companies in
India.
The
publicly listed entity that manufactures and markets generic pharmaceutical
products across the globe has grown by leaps and bounds over the last century.
With
an emphasis on innovation and technology, the company has established a
state-of-the-art research facility – Alembic Research Centre (ARC)-including
formulation research, and 150-bed bioequivalence facility at Vadodara, Gujarat.
Additionally, APL has recently invested in ultra-modern R&D center at
Hyderabad. APL is one of the leading players in the industry to have invested
about 11% of its turnover in R&D.
As
a growth strategy, the company has aggressively started investing in the
international generics market with successful ANDA and DMF filings. APL has
also filings across Canada, Europe, Australia, South Africa & Brazil. The
company caters to the rest of the world markets through branded formulation
sales.
No comments:
Post a Comment